Serum leptin in elderly people: associations with sex hormones, insulin, and adipose tissue volumes.

OBJECTIVE There are few data for associations of serum leptin with body fat, fat distribution, sex hormones, or fasting insulin in elderly adults. We hypothesized that the sex difference in serum leptin concentrations would disappear after adjustment for subcutaneous, but not visceral body fat. Serum leptin would not be associated with sex hormone concentrations or serum fasting insulin after adjusting for body fat and fat distribution. RESEARCH METHODS AND PROCEDURES Subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) volumes were measured using magnetic resonance imaging in a cross-sectional sample of 56 nondiabetic, elderly men and women aged 64 years to 94 years. Serum leptin, sex hormones (testosterone and estrone), sex hormone-binding globulin, and fasting insulin were also measured. Nine women were taking hormone replacement, and five men were clinically hypogonadal. RESULTS Leptin was significantly associated with both SAT and VAT in each sex. Adjustment for SAT reduced the sex difference in leptin by 56%, but adjustment for VAT increased the difference by 25%. Leptin was not associated with serum estrone or hormone replacement therapy in the women, but had a significant, negative association with testosterone in the men that was independent of SAT, but not VAT. Leptin was significantly associated with fasting insulin in both sexes independent of age, sex hormones, sex hormone-binding globulin, VAT and SAT. DISCUSSION Sex difference in serum leptin is partly explained by different amounts of SAT. Studies including both men and women should adjust for SAT rather than total body fat that includes VAT. The sex difference in serum leptin is not due to estrogen, but may be partly explained by testosterone. Testosterone is negatively associated with leptin in men, but the association is confounded with VAT. Leptin is associated with fasting insulin in nondiabetic elderly men and women independent of body fat, fat distribution, or sex hormones.

[1]  R. Stolk,et al.  The acute effect of dexamethasone on plasma leptin concentrations and the relationships between fasting leptin, the IGF‐I/IGFBP system, dehydroepiandrosterone, androstenedione and testosterone in an elderly population , 1998, Clinical endocrinology.

[2]  B. Göke,et al.  Leptin: A Potent Inhibitor of Insulin Secretion , 1997, Peptides.

[3]  M. Horowitz,et al.  Body composition and age in African-American and Caucasian women: relationship to plasma leptin levels. , 1997, Metabolism: clinical and experimental.

[4]  Y. Yazaki,et al.  Serum leptin levels are associated with hyperinsulinemia independent of body mass index but not with visceral obesity. , 1997, Biochemical and biophysical research communications.

[5]  S. Haffner,et al.  Leptin concentrations in women in the San Antonio Heart Study: effect of menopausal status and postmenopausal hormone replacement therapy. , 1997, American journal of epidemiology.

[6]  T. Asano,et al.  Direct Stimulation of Basal Insulin Secretion by Physiological Concentrations of Leptin in Pancreatic β Cells. , 1997, Endocrinology.

[7]  V. Emilsson,et al.  Leptin inhibits insulin secretion and reduces insulin mRNA levels in rat isolated pancreatic islets. , 1997, Biochemical and biophysical research communications.

[8]  S. Kahn,et al.  Evidence That Plasma Leptin and Insulin Levels are Associated With Body Adiposity Via Different Mechanisms , 1997, Diabetes Care.

[9]  C. Bouchard,et al.  Plasma leptin concentrations: gender differences and associations with metabolic risk factors for cardiovascular disease , 1997, Diabetologia.

[10]  M. Wabitsch,et al.  Contribution of androgens to the gender difference in leptin production in obese children and adolescents. , 1997, The Journal of clinical investigation.

[11]  E. Nieschlag,et al.  Strong association between serum levels of leptin and testosterone in men , 1997, Clinical endocrinology.

[12]  W. Rascher,et al.  Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men. , 1997, The Journal of clinical endocrinology and metabolism.

[13]  R. Coleman,et al.  Leptin Directly Alters Lipid Partitioning in Skeletal Muscle , 1997, Diabetes.

[14]  V. Emilsson,et al.  Leptin inhibits glycogen synthesis in the isolated soleus muscle of obese (ob/ob) mice , 1997, FEBS letters.

[15]  E. Ravussin,et al.  Relationship between muscle sympathetic nerve activity and plasma leptin concentration. , 1997, Obesity research.

[16]  L. Tartaglia,et al.  Leptin Receptor Action in Hepatic Cells* , 1997, The Journal of Biological Chemistry.

[17]  M. Laakso,et al.  Leptin concentrations, sex hormones, and cortisol in nondiabetic men. , 1997, The Journal of clinical endocrinology and metabolism.

[18]  H. Perry,et al.  Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. , 1997, The Journal of clinical endocrinology and metabolism.

[19]  S. Coppack,et al.  Relationships Between Plasma Leptin and Insulin Concentrations, But Not Insulin Resistance, in Non‐insulin‐Dependent (Type 2) Diabetes Mellitus , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[20]  M. Laakso,et al.  Leptin concentrations and insulin sensitivity in normoglycemic men , 1997, International Journal of Obesity.

[21]  G. Müller,et al.  Leptin Impairs Metabolic Actions of Insulin in Isolated Rat Adipocytes* , 1997, The Journal of Biological Chemistry.

[22]  S. O’Rahilly,et al.  Depot- and Sex-Specific Differences in Human Leptin mRNA Expression: Implications for the Control of Regional Fat Distribution , 1997, Diabetes.

[23]  P. Zimmet,et al.  Hyperleptinaemia: the Missing Link in the Metabolic Syndrome? , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[24]  R. Jung,et al.  Plasma leptin concentrations and OB gene expression in subcutaneous adipose tissue are not regulated acutely by physiological hyperinsulinaemia in lean and obese humans , 1997, International Journal of Obesity.

[25]  X. Remesar,et al.  Is leptin an insulin counter‐regulatory hormone? , 1997, FEBS letters.

[26]  R. Holman,et al.  UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects. , 1997, The Journal of clinical endocrinology and metabolism.

[27]  E. Ravussin,et al.  Effects of acute hyperinsulinemia on plasma leptin concentrations in insulin-sensitive and insulin-resistant Pima Indians. , 1996, The Journal of clinical endocrinology and metabolism.

[28]  W. Kohrt,et al.  Serum leptin levels are reduced in response to exercise training, but not hormone replacement therapy, in older women. , 1996, The Journal of clinical endocrinology and metabolism.

[29]  S. Haffner,et al.  Leptin concentrations in relation to overall adiposity and regional body fat distribution in Mexican Americans. , 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[30]  S. Phinney,et al.  Gender differences in plasma leptin concentrations , 1996, Nature Medicine.

[31]  S. Klein,et al.  Relationship Between Insulin Sensitivity and Plasma Leptin Concentration in Lean and Obese Men , 1996, Diabetes.

[32]  Robert Ross,et al.  Magnetic resonance imaging provides new insights into the characterization of adipose and lean tissue distribution , 1996 .

[33]  C. Fanelli,et al.  Plasma Leptin and Insulin Relationships in Obese and Nonobese Humans , 1996, Diabetes.

[34]  S. Mudaliar,et al.  Acute and Chronic Effect of Insulin on Leptin Production in Humans: Studies In Vivo and In Vitro , 1996, Diabetes.

[35]  R. Considine,et al.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.

[36]  Rene Devos,et al.  Identification and expression cloning of a leptin receptor, OB-R , 1995, Cell.

[37]  P J Garry,et al.  Cross-sectional age differences in body composition in persons 60+ years of age. , 1995, The journals of gerontology. Series A, Biological sciences and medical sciences.

[38]  J. Bue-Valleskey,et al.  The role of neuropeptide Y in the antiobesity action of the obese gene product , 1995, Nature.

[39]  Steven L. Cohen,et al.  Weight-reducing effects of the plasma protein encoded by the obese gene. , 1995, Science.

[40]  R M Peshock,et al.  Estimation of adipose tissue mass by magnetic resonance imaging: validation against dissection in human cadavers. , 1994, Journal of lipid research.

[41]  L. Sjöström,et al.  Androgen treatment of abdominally obese men. , 1993, Obesity research.

[42]  R Guardo,et al.  Quantification of adipose tissue by MRI: relationship with anthropometric variables. , 1992, Journal of applied physiology.